A detailed history of Ballentine Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 11,794 shares of ZTS stock, worth $2.11 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,794
Previous 11,796 0.02%
Holding current value
$2.11 Million
Previous $2.04 Million 12.72%
% of portfolio
0.04%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$172.58 - $196.48 $345 - $392
-2 Reduced 0.02%
11,794 $2.3 Million
Q2 2024

Aug 06, 2024

SELL
$145.54 - $178.83 $19,938 - $24,499
-137 Reduced 1.15%
11,796 $2.04 Million
Q1 2024

Apr 11, 2024

SELL
$165.67 - $199.94 $17,726 - $21,393
-107 Reduced 0.89%
11,933 $2.02 Million
Q4 2023

Jan 23, 2024

BUY
$151.44 - $200.09 $323,778 - $427,792
2,138 Added 21.59%
12,040 $2.38 Million
Q3 2023

Oct 19, 2023

BUY
$167.14 - $192.77 $23,566 - $27,180
141 Added 1.44%
9,902 $1.72 Million
Q2 2023

Jul 26, 2023

SELL
$160.94 - $186.23 $340,549 - $394,062
-2,116 Reduced 17.82%
9,761 $1.68 Million
Q1 2023

Apr 27, 2023

BUY
$145.48 - $175.02 $356,426 - $428,799
2,450 Added 25.99%
11,877 $1.98 Million
Q4 2022

Jan 27, 2023

BUY
$131.14 - $157.47 $24,392 - $29,289
186 Added 2.01%
9,427 $0
Q3 2022

Oct 26, 2022

BUY
$148.29 - $182.55 $99,947 - $123,038
674 Added 7.87%
9,241 $1.37 Million
Q2 2022

Aug 09, 2022

BUY
$155.97 - $200.09 $1,871 - $2,401
12 Added 0.14%
8,567 $1.47 Million
Q1 2022

May 05, 2022

BUY
$181.39 - $234.03 $3,990 - $5,148
22 Added 0.26%
8,555 $1.61 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $71,084 - $90,660
367 Added 4.49%
8,533 $2.08 Million
Q3 2021

Oct 27, 2021

BUY
$189.29 - $209.69 $4,732 - $5,242
25 Added 0.31%
8,166 $1.59 Million
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $207,035 - $249,650
1,328 Added 19.49%
8,141 $1.52 Million
Q1 2021

May 11, 2021

SELL
$144.0 - $169.39 $28,656 - $33,708
-199 Reduced 2.84%
6,813 $1.07 Million
Q4 2020

Jan 25, 2021

SELL
$157.07 - $174.35 $42,723 - $47,423
-272 Reduced 3.73%
7,012 $1.16 Million
Q3 2020

Oct 22, 2020

SELL
$137.1 - $165.37 $312,313 - $376,712
-2,278 Reduced 23.82%
7,284 $1.21 Million
Q2 2020

Jul 31, 2020

BUY
$111.92 - $142.53 $738,000 - $939,842
6,594 Added 222.17%
9,562 $1.31 Million
Q1 2020

Apr 23, 2020

BUY
$92.66 - $144.94 $23,165 - $36,235
250 Added 9.2%
2,968 $350,000
Q4 2019

Jan 22, 2020

BUY
$116.25 - $133.25 $5,115 - $5,863
44 Added 1.65%
2,718 $360,000
Q3 2019

Oct 21, 2019

SELL
$112.57 - $128.43 $9,118 - $10,402
-81 Reduced 2.94%
2,674 $333,000
Q2 2019

Jul 25, 2019

BUY
$97.98 - $114.28 $269,934 - $314,841
2,755 New
2,755 $312,000
Q4 2018

Feb 04, 2019

SELL
$79.28 - $95.27 $175,446 - $210,832
-2,213 Closed
0 $0
Q3 2018

Oct 30, 2018

BUY
$83.5 - $93.23 $184,785 - $206,317
2,213 New
2,213 $203,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.